Project Oncology®

173 Avsnitt

1. Predictive Models for CAR T-Cell Therapy: Personalizing R/R LBCL Care

   Publicerades: 2025-01-08
2. Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data

   Publicerades: 2025-01-07
3. Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management

   Publicerades: 2025-01-07
4. Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols

   Publicerades: 2025-01-02
5. Treating Second-Line NSCLC: The Efficacy of ADCs Targeting Predictive Biomarkers

   Publicerades: 2024-12-31
6. Analyzing Dato-DXd for Non-Squamous NSCLC with Brain Metastases

   Publicerades: 2024-12-23
7. Treating NSCLC with Durvalumab, Chemotherapy, and Novel Agents: Preliminary Results

   Publicerades: 2024-12-23
8. Dato-DxD for NSCLC: A Review of Final Overall Survival Data from TROPION-Lung01

   Publicerades: 2024-12-23
9. Evaluating Valemetostat and Dato-DXd for NSCLC: An Upcoming Trial

   Publicerades: 2024-12-23
10. Understanding Heparin Resistance: Underlying Mechanisms and Alternative Treatment Options

    Publicerades: 2024-12-16
11. Understanding iMCD Through RNA Sequencing

    Publicerades: 2024-12-16
12. The Future of ITP Care: Exploring New Treatments

    Publicerades: 2024-12-16
13. NSCLC Care: Predicting Response to Dato-DXd with a TROP2 Biomarker

    Publicerades: 2024-12-13
14. Diagnosing Castleman Disease: Key Considerations

    Publicerades: 2024-12-10
15. Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells

    Publicerades: 2024-12-09
16. Poster Pearl: Treating ER+/HER2- mBC with Elacestrant and Endocrine Therapy

    Publicerades: 2024-11-27
17. EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i

    Publicerades: 2024-11-26
18. Investigating the Impact of Momelotinib on Myelofibrosis Patients: A Poster from ASH

    Publicerades: 2024-10-29
19. Poster Pearl: Elacestrant + Abemaciclib for ER+/HER2- Metastatic Breast Cancer

    Publicerades: 2024-10-29
20. The Long-Term Safety of Momelotinib for Myelofibrosis: A Poster from ASH

    Publicerades: 2024-10-29